The Lancet Criticizes RFK Jr.'s Leadership as Health Secretary, Citing Failures
The esteemed medical journal The Lancet has issued a harsh critique of Robert F. Kennedy Jr.'s tenure as the US Secretary of Health and Human Services (HHS), labeling his first year in the role as a failure. The journal, known for its significant contributions to medical research, condemned Kennedy for spreading misinformation and politicizing health policies, which it claims have jeopardized the health and safety of Americans, particularly children.
The Lancet editorial highlights Kennedy's abandonment of his initial promises of transparency and adherence to scientific standards. Shortly after assuming office, Kennedy rescinded a long-standing policy of public commentary on federal health actions, dismissed expert advisors, and issued health recommendations that contradict established scientific evidence. He also halted programs focused on critical health issues such as air pollution and cancer research.
As the head of the HHS, Kennedy oversees major health institutions like the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC). The Lancet accuses him of undermining these agencies, thereby threatening the future of US science and public health. His controversial overhaul of the CDC's childhood vaccine recommendations has been widely rejected across the United States. Additionally, Kennedy's authorization of a contentious vaccine trial in Guinea-Bissau, criticized by the World Health Organization as unethical, has drawn parallels to historical medical scandals.
The editorial further criticizes Kennedy's financial decisions, claiming that HHS under his leadership has invested in discredited science and fringe theories while neglecting promising research areas like mRNA technology and essential disease monitoring. The Lancet's call for Kennedy's resignation aligns with broader demands from the medical and scientific communities for accountability and change.
In response to such criticisms, Kennedy has previously accused prominent medical journals, including The Lancet, of being compromised by pharmaceutical interests, a common rebuttal he employs against detractors. The ongoing conflict underscores the deep divisions between Kennedy's administration and the scientific community regarding public health policy and scientific integrity.